--- title: "FSCA, Field Safety Corrective Action | MedTech Terms" description: "Action taken to reduce a risk of serious deterioration in health associated with a device. Plain-English Post-Market definition for MedTech teams, with examples" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/fsca#term", "name": "Field Safety Corrective Action", "alternateName": "FSCA", "description": "An FSCA is any action taken by a manufacturer to reduce the risk of a serious incident in relation to a device already placed on the market, including device modifications, exchange, return, destruction, or advice to users (FSN).", "url": "https://medtechterms.com/terms/fsca", "termCode": "fsca", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/fsca#article", "headline": "FSCA, Field Safety Corrective Action", "description": "Action taken to reduce a risk of serious deterioration in health associated with a device.", "url": "https://medtechterms.com/terms/fsca", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/fsca" }, "about": { "@id": "https://medtechterms.com/terms/fsca#term" }, "articleSection": "Post-Market", "inLanguage": "en", "keywords": "Field Safety Corrective Action, FSCA, Post-Market, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "MDCG Vigilance Guidance", "url": "https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en", "publisher": { "@type": "Organization", "name": "MDCG" } }, { "@type": "CreativeWork", "name": "FDA MAUDE Database", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "FDA Recalls - Medical Devices", "url": "https://www.fda.gov/medical-devices/medical-device-safety/medical-device-recalls", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/vigilance#term", "name": "Medical Device Vigilance", "url": "https://medtechterms.com/terms/vigilance" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/recall#term", "name": "Medical Device Recall", "url": "https://medtechterms.com/terms/recall" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Post-Market", "item": "https://medtechterms.com/terms?cat=Post-Market" }, { "@type": "ListItem", "position": 4, "name": "Field Safety Corrective Action", "item": "https://medtechterms.com/terms/fsca" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/fsca#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary goal of an FSCA?", "acceptedAnswer": { "@type": "Answer", "text": "The primary goal of an FSCA is to proactively reduce the risk of serious incidents or harm to patients, users, or other persons associated with a medical device already in circulation." } }, { "@type": "Question", "name": "How does an FSCA differ from a product recall?", "acceptedAnswer": { "@type": "Answer", "text": "An FSCA is a broad category of actions taken to reduce risk, which can include a product recall, but also encompasses less drastic measures such as device modifications, labeling changes, or providing updated user advice. A recall specifically involves removal of the device from the market." } }, { "@type": "Question", "name": "Who is responsible for initiating an FSCA?", "acceptedAnswer": { "@type": "Answer", "text": "The manufacturer of the medical device is primarily responsible for identifying the need for and initiating an FSCA, in cooperation with regulatory authorities." } }, { "@type": "Question", "name": "What is a Field Safety Notice (FSN)?", "acceptedAnswer": { "@type": "Answer", "text": "A Field Safety Notice is the communication sent by a manufacturer to users or customers in conjunction with an FSCA to inform them about the action being taken and its implications." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Post-Market](/terms?cat=Post-Market) 6. / 7. Field Safety Corrective Action [All terms](/terms) Post-Market [Quality System](/ecosystems/quality-system)[Post-Market & Safety](/ecosystems/post-market-safety)[Startup Lifecycle](/ecosystems/startup-lifecycle)FSCA # Field Safety Corrective Action Action taken to reduce a risk of serious deterioration in health associated with a device. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition An FSCA is any action taken by a manufacturer to reduce the risk of a serious incident in relation to a device already placed on the market, including device modifications, exchange, return, destruction, or advice to users (FSN). What the regulation says Under the [EU Medical Device Regulation](/terms/mdr) ( [MDR](/terms/mdr-reporting)) 2017/745, manufacturers are required to implement Field Safety Corrective Actions (FSCAs) to mitigate risks associated with devices already on the market. The FDA, in 21 CFR Part 806, outlines similar manufacturer reporting requirements for corrections and removals, which can align with the concept of an FSCA. [ISO 14971](/terms/iso-14971):2019, while not directly mandating FSCAs, provides a framework for risk management that informs decisions leading to such actions. ## What this means in practice FSCAs are reported to Competent Authorities in the EU and may correspond to FDA recalls, depending on classification. ## Examples - A manufacturer issues an FSCA to update the software of an infusion pump to correct a bug that could lead to incorrect dose delivery. - An FSCA is initiated to replace a specific component in an implantable device after reports of premature degradation, potentially affecting patient safety. - A Field Safety Notice is distributed to advise healthcare professionals on a revised cleaning protocol for a reusable surgical instrument to prevent cross-contamination. Common pitfalls - • A common pitfall is failing to promptly initiate an FSCA when new risk information emerges, potentially leading to more severe patient harm and regulatory penalties. - • Manufacturers sometimes incorrectly assume that minor product updates do not require an FSCA, even if they address a potential safety concern. - • Not all product changes or customer communications qualify as an FSCA, leading to confusion about reporting obligations. - • Failure to adequately communicate the FSCA to all affected parties, including users and distributors, can undermine its effectiveness. - • Inadequate documentation of the FSCA process and its outcomes can lead to compliance issues during audits. ## Frequently asked questions What is the primary goal of an FSCA? The primary goal of an FSCA is to proactively reduce the risk of serious incidents or harm to patients, users, or other persons associated with a medical device already in circulation. How does an FSCA differ from a product recall? Who is responsible for initiating an FSCA? What is a Field Safety Notice (FSN)? ## Cross-references ### See also Closely related context worth reading. - [ Medical Device Recall ](/terms/recall) ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Post-Market Medical Device Vigilance Reporting and management of serious incidents and field safety corrective actions. ](/terms/vigilance)[ Post-Market Medical Device Recall Removal or correction of a marketed device that violates FDA law. ](/terms/recall) ### EU MDR Essentials · From this learning path [ Post-Market Periodic Safety Update Report(PSUR) Periodic EU MDR/IVDR report summarizing post-market surveillance findings. ](/terms/psur?from=eu-mdr-essentials)[ Regulatory CE Mark Mandatory European conformity mark for medical devices placed on the EU market. ](/terms/ce-mark?from=eu-mdr-essentials)[ Regulatory EU In Vitro Diagnostic Regulation(IVDR) Regulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU. ](/terms/ivdr?from=eu-mdr-essentials)[ Regulatory EUDAMED European Database on Medical Devices. ](/terms/eudamed?from=eu-mdr-essentials) ### Post-Market Mastery · From this learning path [ Post-Market Medical Device Reporting (FDA)(MDR) FDA mechanism for receiving reports of device-related deaths, serious injuries, and malfunctions. ](/terms/mdr-reporting?from=post-market-mastery)[ Post-Market Post-Market Surveillance(PMS) Activities to monitor device safety and performance after market release. ](/terms/post-market-surveillance?from=post-market-mastery)[ Quality & Risk Complaint Handling Process for receiving, evaluating, and responding to device complaints. ](/terms/complaint-handling?from=post-market-mastery)[ Quality & Risk Corrective and Preventive Action(CAPA) Systematic process to investigate and resolve quality issues and prevent recurrence. ](/terms/capa?from=post-market-mastery) ### IVDR Essentials · From this learning path [ Regulatory Notified Body(NB) EU-designated organization that assesses conformity of medical devices under MDR and IVDR. ](/terms/notified-body?from=ivdr-essentials)[ Post-Market Post-Market Performance Follow-up(PMPF) The IVDR counterpart of PMCF: ongoing collection and analysis of performance data after CE certification. ](/terms/pmpf?from=ivdr-essentials)[ Post-Market PSUR (IVDR Specific) Periodic Safety Update Report obligations for IVDs under EU IVDR Article 81. ](/terms/psur-ivdr?from=ivdr-essentials)[ Clinical & Trials Clinical Evaluation Plan(CEP) EU MDR document that defines the scope, methods, and acceptance criteria for the clinical evaluation that will be reported in the Clinical Evaluation Report (CER). ](/terms/clinical-evaluation-plan?from=ivdr-essentials) Cited by Where this term appears across MedTech Terms. Learning paths (3) - [EU MDR Essentials](/paths/eu-mdr-essentials)Lesson 9 of 9 - [Post-Market Mastery](/paths/post-market-mastery)Lesson 4 of 9 - [IVDR Essentials](/paths/ivdr-essentials)Lesson 13 of 13 Ecosystems (3) - [Quality System](/ecosystems/quality-system) - [Post-Market & Safety](/ecosystems/post-market-safety) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Mentioned in recent activity 10 entries Recalls (10) [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff End Grasping Forceps, Model/Catalog Number: DVF4022-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2077-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Maculorhexis Forceps, Model/Catalog Number: DVF4019-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2075-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Serrated Forceps, Model/Catalog Number: DVF4016-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2072-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Super Grip Forceps, Model/Catalog Number: DVF4034-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2079-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Super Grip Forceps, Model/Catalog Number: DVF4034-25 ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2078-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Nano Tapered AWH Forceps, Model/Catalog Number: DVF4005-25 ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2070-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 23ga DEX Maculorhexis Forceps, Model/Catalog Number: DVF4019-23 ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2073-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Asymmetrical Tano Forceps, Model/Catalog Number: DVF4014-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2071-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Maculorhexis Forceps, Model/Catalog Number: DVF4019-25 ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2074-2026) Class II · 2026-03-25 [DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps, Model/Catalog Number: DVF4005-23 ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2069-2026) Class II · 2026-03-25 ## Latest in MedTech [View all](/latest?term=fsca) Recent regulatory actions, publications, and trials matched to this term. Updated daily. - Recall 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Maculorhexis Forceps, Model/Catalog Number: DVF4019-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2075-2026) Class II · Katalyst Surgical, LLC - Recall 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Serrated Forceps, Model/Catalog Number: DVF4016-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2072-2026) Class II · Katalyst Surgical, LLC - Recall 2026-03-25 [DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff End Grasping Forceps, Model/Catalog Number: DVF4022-25-S ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2077-2026) Class II · Katalyst Surgical, LLC ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 MDCG· 1 FDA· 2 1. [1 MDCG Vigilance Guidance Verified MDCG · health.ec.europa.eu ](https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en) 2. [2 FDA MAUDE Database Verified FDA · accessdata.fda.gov ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm) 3. [3 FDA Recalls - Medical Devices Verified FDA · fda.gov ](https://www.fda.gov/medical-devices/medical-device-safety/medical-device-recalls) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Post-market cybersecurity surveillance? We help MedTech teams stand up vulnerability monitoring, coordinated disclosure, and post-market reporting workflows. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Post-Market Acronym FSCA Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=fsca) Learn in 60 seconds Card Lesson Quiz Action taken to reduce a risk of serious deterioration in health associated with a device. - · FSCAs are reported to Competent Authorities in the EU and may correspond to FDA recalls, depending on classification. Remember this Watch out: A common pitfall is failing to promptly initiate an FSCA when new risk information emerges, potentially leading to more severe patient harm and regulatory penalties. Related terms - [Medical Device Vigilance ](/terms/vigilance) - [Medical Device Recall ](/terms/recall) You may also need Auto-suggested from Post-Market and shared keywords. - [Removal vs Correction (21 CFR 806) ](/terms/removal-vs-correction) - [Post-Market Surveillance(PMS) ](/terms/post-market-surveillance) - [Customer Notification Letter ](/terms/customer-notification) - [Field Action vs Recall ](/terms/field-action-vs-recall) - [Manufacturer Incident Report(MIR) ](/terms/mir) - [5-Day Report ](/terms/five-day-report) [All Post-Market terms](/terms?cat=Post-Market) From the Blue Goat network Related resources and services on this topic. - [ Code Blue Real medical device cybersecurity incidents and their lessons. ](https://codebluechart.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)